Prof. Nianguo Dong: World Titan in Heart Transplantation, Maglev Artificial Hearts & Complex Pediatric Cardiac Surgery at Wuhan Union Hospital

1. Surgical Leadership: A Global Giant in Cardiac Replacement & Reconstruction

Professor Nianguo Dong is an internationally acclaimed cardiovascular surgeon and Director of the Department of Cardiovascular Surgery at Wuhan Union Hospital, affiliated with Tongji Medical College of Huazhong University of Science and Technology (HUST). Standing among the most prolific cardiac transplant surgeons in global medical history, Professor Dong has personally led over 1,100 orthotopic heart transplantations, setting world benchmarks for surgical volume, complex graft survival, and innovative circulatory mechanical support.

Under Professor Dong's leadership, the cardiovascular surgery center at Wuhan Union Hospital has evolved into one of the world's most formidable surgical hubs for end-stage heart failure, artificial heart bioengineering, and neonatal congenital heart disease repair.

2. Pushing the Boundaries of Heart Transplantation

Professor Dong’s transplant service is internationally renowned for surmounting physiological and chronological barriers once considered insurmountable:

• Extreme Age Spans in Cardiac Grafting: Successfully performed the world’s oldest recorded heart transplant at age 76 and Asia’s youngest successful heart transplant in an infant just 53 days old, proving that advanced age and extreme low body weight are no longer absolute contraindications under meticulous surgical precision.
• Sensitized & High-PRA Heart Recipients: Implementing pre-transplant plasma exchange, biological desensitization, and perioperative donor-specific antibody (DSA) suppression to achieve long-term survival in immunologically complex candidates.
• Marginal & Complex Donors: Pioneering myocardial protection solutions and warm blood perfusion strategies that optimize donor organ viability across extended ischemic times.
• Pediatric Cardiac Transplantation: Outstanding multi-year survival outcomes for pediatric cardiomyopathy, complex single-ventricle anatomy, and post-Fontan failure patients.

3. Pioneering Artificial Hearts: Magnetic Levitation VAD Breakthroughs

Recognizing the chronic global shortage of donor hearts, Professor Dong has spearheaded the indigenous development and clinical implementation of mechanical circulatory assist systems:

• World’s First 45-Gram Pediatric Maglev Artificial Heart (2025): Professor Dong led the design, animal validation, and successful first-in-human surgical implantation of an ultra-miniaturized 45g magnetic levitation ventricular assist device (VAD). Specially tailored for infants and young children with end-stage heart failure, this device overcomes the hemocompatibility and anatomical sizing constraints of adult VADs.
• Adult Full Maglev VAD Implantation: Extensive clinical application of centrifugal continuous-flow magnetic levitation left ventricular assist devices as destination therapy (DT) or bridge-to-transplant (BTT), restoring normal hemodynamics and physical vitality in patients ineligible for immediate donor matching.
• Innovative Retrievable Atrial Flow Regulators (Shunts): Developed novel percutaneous and minimally invasive atrial shunting devices designed to decompress elevated left atrial pressure in heart failure with preserved ejection fraction (HFpEF).

4. Critical Congenital Heart Defect (CHD) Surgery & National Guidelines

Beyond heart transplantation and artificial heart devices, Professor Dong is a national authority in complex congenital heart defects:

• Neonatal & Infant Anatomical Repair: Performing arterial switch operations (ASO) for transposition of the great arteries, repair of total anomalous pulmonary venous connection (TAPVC), Truncus Arteriosus reconstruction, and single-stage repair of interrupted aortic arch with ventricular septal defect in low-birth-weight newborns.
• National Guidelines & Academic Consensuses: Key author and chairman behind multiple national guidelines and expert consensus statements published in the Chinese Circulation Journal, standardizing perioperative management for heart transplantation and ventricular assist device therapy across China.

5. Benchmark Clinical Case Scenarios

Professor Dong’s unit routinely accomplishes cardiac rescues celebrated across international surgical societies:

• Case Scenario 1 (World-Record 76-Year-Old Heart Transplant): A 76-year-old patient with ischemic end-stage cardiomyopathy, severe pulmonary hypertension, and multi-organ decompensation was evaluated under Professor Dong’s strict physiological protocol. Following donor optimization and rapid orthotopic bicaval transplantation, the patient experienced smooth hemodynamic recovery, ambulated on day 5, and was discharged with excellent long-term quality of life.
• Case Scenario 2 (Asia's Youngest 53-Day-Old Infant Transplant): An infant weighing under 3.8 kg presented in irreversible dilated cardiomyopathy and refractory cardiogenic shock. Professor Dong executed precision microscopic vascular anastomoses on coronary and great vessels under deep hypothermic circulatory arrest. The donor heart functioned immediately, achieving full developmental milestones on extended pediatric follow-up.

6. Accessing Professor Nianguo Dong for International Patients

For international patients, pediatric families, and overseas clinicians seeking urgent evaluation, second surgical opinions, or mechanical circulatory device consultation with Professor Nianguo Dong, organized clinical preparation is paramount:

1. Comprehensive Cardiac Dossier Assembly: Detailed echocardiograms with Doppler hemodynamics, coronary angiograms or cardiac CT angiography (CTA), right heart catheterization hemodynamic profiles (PA pressures, PVR, wedge pressures), 12-lead ECGs, and cardiac MRI (CMR) series.
2. Urgent Risk & Feasibility Triage: Immediate assessment of patient acuity to establish candidacy for conventional corrective surgery, VAD mechanical assist implantation, or formal cardiac transplant listing.
3. Physician Review & Surgical Plan: Authorized evaluation of records by Professor Dong’s senior surgical committee to formulate an individualized operative or bridging roadmap.
4. Full-Spectrum Concierge Support: Dedicated coordination including international medical transfer arrangements, specialized cardiac intensive care (CICU) bed reservation, bilingual clinical liaison, and long-term remote follow-up.

7. Inquire & Request a Clinical Assessment

China Medical Concierge - Shanghai (CMCS) is an independent health management and medical concierge service. We connect international patients and expatriates with leading specialists and premier national academic medical centers across China.

To inquire about case reviews, artificial heart/VAD candidacy assessments, or coordination with Professor Nianguo Dong’s cardiovascular surgery team, please reach out directly through our official channels: